Overview

This trial is active, not recruiting.

Condition sleep apnea
Sponsor RWTH Aachen University
Collaborator ResMed
Start date June 2011
End date December 2016
Trial size 1300 participants
Trial identifier NCT01830036, 10-007

Summary

Prevalence of sleep-related breath disturbance in patients in cardiac rehabilitation.

The aim of the register is to enable a better diagnosis and early treatment initiation in the context of secondary prevention. In addition to the prevalence, the further course of the patients shall be documented after hospital discharge to verify any gaps (sleep laboratory, therapy introduction) and emphasize the importance of rehabilitation and to examine the possibility of initiating therapy in rehabilitation.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Time perspective prospective
Arm
cardiological treatment

Primary Outcomes

Measure
cardiological treatment
time frame: April 2013

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - terminal cardiac treatment in cardiac rehabilitation facility - for example: Myocardial infarction, bypass surgery, stent implantation, valve replacement, ICD, CRT, pacemakers, heart failure Exclusion Criteria: - no informed consent form signed - limited consent capacity (Dementia, addiction, psychosis) - pregnancy

Additional Information

Official title RehaSleep Register - Prevalence of Sleep Apnea in Cardiac Rehabilitation
Principal investigator Stefan Krüger, Univ.-Prof.
Trial information was received from ClinicalTrials.gov and was last updated in September 2015.
Information provided to ClinicalTrials.gov by RWTH Aachen University.